This inventor holds 1 USPTO granted patent. Top assignees: Assistance Publique-Hopitaux De Paris, Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023
Title: Innovator Jérôme Verine: Pioneering HLA-G Research in Antony, France
Introduction
Jérôme Verine is a notable inventor based in Antony, France, who has made significant contributions to the field of biotechnology. With a focus on HLA-G molecules, his research aims to enhance therapeutic applications, particularly in the realms of immunology and diagnostics.
Latest Patents
Jérôme Verine holds a patent for "HLA-G transcripts and isoforms and their uses." This patent focuses on the therapeutic applications of novel HLA-G isoforms—specifically new RNA transcripts and proteins derived from the HLA-G gene. The patent describes pharmaceutical compositions that include these novel isoforms, along with specific primers and antibodies targeting these proteins. Furthermore, it outlines potential diagnostic and therapeutic uses for these groundbreaking molecules.
Career Highlights
Throughout his career, Jérôme Verine has worked with esteemed organizations such as the Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA) and Assistance Publique-Hôpitaux de Paris. His contributions to these institutions have played a crucial role in advancing research and applications in biotechnology.
Collaborations
Jérôme Verine has collaborated with distinguished coworkers, including Edgardo Delfino Carosella and Diana Tronik-Le Roux. Together, they have explored innovative solutions and paved the way for groundbreaking research in their respective fields.
Conclusion
Through his dedicated research and innovative spirit, Jérôme Verine continues to make a lasting impact in the world of biotechnology. His patent on HLA-G transcripts and isoforms represents a significant advancement, promising new horizons for therapeutic and diagnostic applications in immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile